374148167	374148167	CD	B-NP	O
|	|	JJ	I-NP	O
S	S	NN	I-NP	O
|	|	NN	I-NP	O
94481519	94481519	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0139898	0139898	CD	B-NP	O
|	|	CC	I-NP	O
10/22/2006	10/22/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ALTERED	ALTERED	NNP	I-NP	I-protein
MENTAL	MENTAL	NNP	I-NP	I-protein
STATUS	STATUS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/17/2006	2/17/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/28/2006	2/28/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
TUXHORN	TUXHORN	NN	B-NP	O
,	,	,	O	O
LEVI	LEVI	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADDENDUM	ADDENDUM	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Starting	Start	VBG	B-VP	O
on	on	IN	B-PP	O
6/13/06	6/13/06	CD	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
agitation	agitation	NN	B-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
Ativan	Ativan	NNP	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
agitated	agitate	VBN	I-VP	O
and	and	CC	O	O
required	require	VBN	B-VP	O
multiple	multiple	JJ	B-NP	O
code	code	NN	I-NP	O
greys	grey	NNS	I-NP	O
to	to	TO	B-VP	O
sedate	sedate	VB	I-VP	O
him	him	PRP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
team	team	NN	I-NP	O
meeting	meeting	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
8/13/06	8/13/06	CD	B-NP	O
and	and	CC	O	O
per	per	IN	B-PP	O
psychiatry	psychiatry	NN	B-NP	O
recommendations	recommendation	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
250	250	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
of	of	IN	B-PP	O
Depakote	Depakote	NNP	B-NP	O
,	,	,	O	O
Haldol	Haldol	NNP	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
just	just	RB	B-NP	O
Monday-Wednesday-Friday	Monday-Wednesday-Friday	NNP	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
before	before	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Depakote	Depakote	NNP	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
39.7	39.7	CD	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
Depakote	Depakote	NNP	B-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
with	with	IN	B-PP	O
Haldol	Haldol	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
behavior	behavior	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
x3	x3	CD	I-NP	O
and	and	CC	O	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
additional	additional	JJ	I-NP	O
events	event	NNS	I-NP	O
to	to	TO	B-VP	O
report	report	VB	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
on	on	IN	B-PP	O
10/26/06	10/26/06	CD	B-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
IV	IV	CD	I-NP	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
spiking	spike	VBG	I-VP	O
fevers	fever	NNS	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
audible	audible	JJ	B-NP	O
rales	rale	NNS	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
tolerate	tolerate	JJ	B-NP	O
regular	regular	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
ensuring	ensure	VBG	I-VP	O
adequate	adequate	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
adjusting	adjust	VBG	B-VP	O
diet	diet	NN	B-NP	O
per	per	IN	B-PP	O
endocrine	endocrine	JJ	B-NP	O
needs	need	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
endocrine	endocrine	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
addendum	addendum	NN	I-NP	O
to	to	TO	B-PP	O
6/13/06	6/13/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
ultimately	ultimately	RB	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
with	with	IN	B-PP	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
aspart	aspart	VBP	B-VP	O
q.a.c.	q.a.c.	NN	B-NP	O
breakfast	breakfast	NN	I-NP	O
and	and	CC	O	O
lunch	lunch	NN	B-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
aspart	aspart	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
dinner	dinner	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
light	light	JJ	I-ADJP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
only	only	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
aspart	aspart	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
as	as	IN	B-PP	O
insulin	insulin	NN	B-NP	O
stacks	stack	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
very	very	RB	B-ADVP	O
easily	easily	RB	I-ADVP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
100s	100	NNS	I-NP	O
consistently	consistently	RB	B-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
next	next	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
aspart	aspart	NN	B-NP	O
be	be	VB	B-VP	O
either	either	CC	O	O
halved	halve	VBN	B-VP	O
or	or	CC	I-VP	O
held	hold	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
easily	easily	RB	B-ADVP	O
becomes	become	VBZ	B-VP	O
hypoglycemic	hypoglycemic	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
recognize	recognize	VB	I-VP	O
the	the	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
himself	himself	PRP	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
100-200	100-200	CD	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
ID	ID	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
spike	spike	VB	I-VP	O
fevers	fever	NNS	B-NP	O
on	on	IN	B-PP	O
9/22/06	9/22/06	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
T.	T.	NNP	I-NP	O
max	max	NN	I-NP	O
of	of	IN	B-PP	O
100.6	100.6	CD	B-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
failed	fail	VBD	B-VP	O
to	to	TO	I-VP	O
show	show	VB	I-VP	O
anything	anything	NN	B-NP	O
as	as	IN	B-SBAR	O
did	do	VBD	O	O
sputum	sputum	NN	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/18/06	5/18/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
spiked	spike	VBD	B-VP	O
to	to	TO	B-PP	O
101.2	101.2	CD	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
cefpodoxime	cefpodoxime	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cefpodoxime	cefpodoxime	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
dosed	dose	VBN	I-VP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
on	on	IN	B-PP	O
Monday-Wednesday-Friday	Monday-Wednesday-Friday	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
disposition	disposition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
on	on	IN	B-PP	O
Monday-Wednesday-Friday	Monday-Wednesday-Friday	NNP	B-NP	O
and	and	CC	O	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
medication	medication	NN	I-NP	O
Rx	Rx	NN	I-NP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
care	care	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
behavior	behavior	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
please	please	VB	B-VP	O
c.c.	c.c.	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Donte	Donte	NNP	I-NP	O
Tasker	Tasker	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Byron	Byron	NNP	I-NP	O
Hague	Hague	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bolin	Bolin	NNP	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
discharge	discharge	NN	I-NP	O
summary	summary	NN	I-NP	O
.	.	.	O	O

ADDENDUM	ADDENDUM	NNP	B-NP	O
TO	TO	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
PhosLo	PhosLo	NNP	B-NP	O
2001	2001	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Depakote	Depakote	NNP	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Haldol	Haldol	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
on	on	IN	B-PP	O
Monday-Wednesday-Friday	Monday-Wednesday-Friday	NNP	B-NP	O
given	give	VBN	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
350	350	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
cefpodoxime	cefpodoxime	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
on	on	IN	B-PP	O
Monday-Wednesday-Friday	Monday-Wednesday-Friday	NNP	B-NP	O
for	for	IN	B-PP	O
eight	eight	CD	B-NP	O
doses	dose	NNS	I-NP	O
given	give	VBN	B-VP	O
after	after	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
,	,	,	O	O
Nephrocaps	Nephrocap	VBZ	B-VP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
sevelamer	sevelamer	NN	B-NP	O
2004	2004	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
diskus	disku	VBZ	B-VP	O
250/50	250/50	CD	B-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lantus	Lantus	NNP	B-NP	O
7	7	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
once	once	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
and	and	CC	O	O
once	once	RB	B-ADVP	O
evening	evening	NN	B-NP	O
,	,	,	O	O
aspart	aspart	NN	B-NP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
before	before	IN	B-PP	O
lunch	lunch	NN	B-NP	O
,	,	,	O	O
aspart	aspart	RB	B-VP	O
sliding	slide	VBG	I-VP	O
scale	scale	NN	B-NP	O
starting	start	VBG	B-VP	O
at	at	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
125	125	CD	B-NP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
125-300	125-300	CD	I-NP	O
give	give	VBP	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
301-350	301-350	CD	I-NP	O
give	give	VBP	B-VP	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
351-400	351-400	CD	I-NP	O
give	give	VBP	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
400-450	400-450	CD	I-NP	O
give	give	VBP	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
butt	butt	NN	I-NP	O
paste	paste	NN	I-NP	O
topical	topical	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
p.r.n.	p.r.n.	NN	B-NP	O
Tylenol	Tylenol	NN	I-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
temperature	temperature	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
Haldol	Haldol	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
three	three	CD	I-NP	O
doses	dose	NNS	I-NP	O
given	give	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
please	please	VB	B-VP	O
check	check	NN	B-NP	O
QTC	QTC	NNP	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
.	.	.	O	O

Loperamide	Loperamide	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
6-4599203	6-4599203	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Rickie	Rickie	NNP	B-NP	O
Botros	Botros	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Ston	Ston	NNP	I-NP	O
Snahsi	Snahsi	NNP	I-NP	O
Cord	Cord	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Reuben	Reuben	NNP	B-NP	O
Willett	Willett	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Reidettefirm	Reidettefirm	NNP	I-NP	O
Stook	Stook	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Tamp	Tamp	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Freeman	Freeman	NNP	B-NP	O
Hoskie	Hoskie	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Landter	Landter	NNP	I-NP	O
Rock	Rock	NNP	I-NP	O
Haysna	Haysna	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SPIRER	SPIRER	NN	B-NP	B-protein
,	,	,	O	O
SANFORD	SANFORD	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GRAVETT	GRAVETT	NNP	B-NP	O
,	,	,	O	O
JACQUES	JACQUES	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0697576	0697576	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/23/06	5/23/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/23/06	5/23/06	CD	B-NP	O

